Two Different Primary Carcinomas in One Breast - Diagnostic and Therapeutic Challenge: A Case Report

• Authors: Arkadiusz Jeziorski , Robert Kubiak , Janusz Piekarski
• Languages of publication: EN

Abstracts

EN

We present a case of 44-year old women with two primary carcinomas diagnosed in one breast. The carcinomas were invasive mixed ductal-lobular and lobular invasive carcinoma. This specific case was difficult to treat because these carcinomas are differentially susceptible to hormonal treatment. We refrained from making therapeutic decisions based solely on characteristics of the first primary would be improper because important therapeutic option (hormonal treatment) would not be used to treat the other primary. Therefore, the treatment would have been suboptimal. In our opinion, this case supports the close examination of biological characteristics of each carcinoma focus, especially if greater than one cancer focus with different morphology exists in the breast tissue.

Keywords

EN

breast cancer; diagnostics; treatment; immunohistochemistry; estrogen receptor; progesterone receptor

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2007
• Volume: 79
• Issue: 7
• Pages: 508-511

Dates

published

1 - 7 - 2007

online

27 - 11 - 2007

Contributors

author

Arkadiusz Jeziorski

• Department of Surgical Oncology Chair of Oncology, Medical University in Łódź

author

Robert Kubiak

• Department of Pathology Chair of Oncology, Medical University in Łódź

author

Janusz Piekarski

• Department of Surgical Oncology Chair of Oncology, Medical University in Łódź

References

• Jeziorski A: Rak piersi. W: Kordek R, Jassem J, Krzakowski M, Jeziorski A (red.) Onkologia. Podręcznik dla studentów medycyny i lekarzy. Wyd. 1. Gdańsk 2003, s. 167-79.
• Piekarski J, Jeziorski A, Wroński K.: Wzrasta częstość występowania obustronnych jednoczasowych i dwuczasowych raków piersi u kobiet. Nowotwory - J Oncol 2003; 53 (supl. 1): s59-60.
• Piekarski J, Jeziorski A, Sęk P.: Wieloogniskowość naciekających raków przewodowych i zrazikowych piersi. Nowotwory - J Oncol 2003; 53 (supl. 1): s59.
• Chaudary MA, Millis RR, Hoskins EO et al.: Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984; 71: 711-14.
• EORTC Breast Cancer Group.: Manual for Clinical Research in Breast Cancer. 5th edition. EORTC. Glasgow 2004: s92.
• Piekarski J: Obustronny rak piersi - dwa pierwotne raki czy jeden rak pierwotny i jego przerzut. Nowotwory - J Oncol 2005; 55: 395-400.
• Bailey MJ, Royce C, Sloane JP et al.: Bilateral carcinoma of the breast. Br J Surg 1980; 67: 514-16.
• Carmichael AR, Bendall S, Lockerbie L et al.: The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral disease. Eur J Surg Oncol 2002; 28: 388-91.
• Heron DE, Komarnicky LT, Hyslop T et al.: Bilateral breast carcinoma. Risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88: 2739-50.
• Hungness ES, Safa M, Shaughnessy EA et al.: Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 2000; 128: 702-07.
• Gustafsson A, Tartter PI, Brower ST et al.: Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg 1994; 178: 111-16.
• Jeziorski A, Piekarski J, Berner J.: Obustronny rak piersi w badaniach własnych. Onkol Pol 1998; 3-4: 137-42.
• De la Rochefordiere A, Asselain B, Scholl S et al.: Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994; 30: 35-41.
• Gollamudi SV, Gelman RS, Peiro G et al.: Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer 1997; 79: 1362-69.
• Jassem J, Krzakowski M, Olszewski W i wsp.: Rak piersi. Zalecenia diagnostyczno-terapeutyczne Polskiej Unii Onkologii. Nowotwory - J Oncol 2003; 53: 300-24.
• Goldhirsch A, Glick JH, Gelber RD et al.: Meeting highlights: International Expert Consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569-83.[WoS]

Identifiers

DOI

10.2478/v10035-007-0079-6